How GLP-1 Works in the Body Im excited to share how GLP-1 works in the body and why its so effective
Antioxidants help fight oxidation, which is caused when body cells utilise oxygen
Current Regulatory Status in the UK and What to Expect Next Retatrutide has not been approved by the MHRA or EMA and is only available within authorised clinical trials
Vitamin B12 deficiency. SW London Integrated Medicines Optimisation Committee
This article discusses advantages and disadvantages of pioglitazone therapy, selecting patients who may be candidates for pioglitazone therapy, and considerations for prescribing in value-based settings
Adverse Reactions in Clinical Trials in Adults with Obesity or Overweight for Weight Reduction WEGOVY 2.4 mg Subcutaneous Injection Weekly Dosage WEGOVY was evaluated for safety in 3 randomized, double-blind, placebo-controlled trials that included 2,116 adult patients with obesity or overweight treated with 2.4 mg WEGOVY injection for up to 68 weeks and a 7-week off-drug follow-up period [see Clinical Studies (14.2)]